0001209191-20-044378.txt : 20200731 0001209191-20-044378.hdr.sgml : 20200731 20200731210559 ACCESSION NUMBER: 0001209191-20-044378 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190909 FILED AS OF DATE: 20200731 DATE AS OF CHANGE: 20200731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BILINSKY IGOR CENTRAL INDEX KEY: 0001594604 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 201067615 MAIL ADDRESS: STREET 1: C/O VICAL INCORPORATED STREET 2: 10390 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-09-09 2019-09-09 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001594604 BILINSKY IGOR 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 0 1 0 0 Chief Business Officer Stock Option 5.33 2019-09-09 4 A 0 150000 0.00 A 2029-09-09 Common Stock 150000 150000 D The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5. One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Persons continued employment or service with the Issuer on each such date. /s/ Hazel M. Aker, Attorney-in-fact 2020-07-31